P Beninger - Clinical Therapeutics, 2024 - clinicaltherapeutics.com
For the treatment of mild to moderate COVID-19 in adults who are at high risk of progression
to severe COVID-19, including hospitalization or death. Paxlovid is the fourth drug—and first …